|Bid||36.2500 x 400|
|Day's Range||40.7200 - 41.3800|
|52 Week Range||27.8200 - 43.6200|
|PE Ratio (TTM)||-80.78|
|Earnings Date||Jul 31, 2017 - Aug 4, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||41.29|
Categories: Yahoo FinanceGet free summary analysis Haemonetics Corp. reports financial results for the year ended March 31, 2017. We analyze the earnings along side the following peers of Haemonetics Corp. – Thermo Fisher Scientific Inc., Stryker Corporation, Becton, Dickinson and Company, C. R. Bard, Inc., Cerus Corporation, Baxter International Inc., PerkinElmer, Inc., Cytori Therapeutics, Inc. and Johnson ... Read more (Read more...)
Haemonetics Corp (NYSE:HAE) files its latest 10-K with SEC for the fiscal year ended on March 31, 2017.
BRAINTREE, Mass., May 22, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that it will host an investor and analyst meeting on Monday, June 19 th from 10:00am to 2:00pm Eastern Time ...